Bio Investment Portfolios

Belite Bio to Highlight Tinlarebant at ARVO 2024, Targeting Stargardt Disease and Dry AMD May 2, 2024

Belite Bio Announces Participation in Discovery One-on-One Investor Conference Dec 1, 2023